Weighted gene coexpression network analysis identifies critical genes in different subtypes of acute myeloid leukaemia

References

• Wang H, Naghavi M, Allen C, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459–1544.
   PubMed Web of Science ®Google Scholar
• Sites A. SEER cancer statistics review 1975-2011. Bethesda (MD): National Cancer Institute; 2014.
   Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Li S, Garrett-Bakelman FE, Chung SS, et al. Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia. Nat Med. 2016;22(7):792–799.
   PubMed Web of Science ®Google Scholar
• Timms JA, Relton CL, Rankin J, et al. DNA methylation as a potential mediator of environmental risks in the development of childhood acute lymphoblastic leukemia. Epigenomics. 2016;8(4):519–536.
   PubMed Web of Science ®Google Scholar
• Iacobucci I, Mullighan CG. Genetic basis of acute lymphoblastic leukemia. J Clin Oncol. 2017;35(9):975–983.
   PubMed Web of Science ®Google Scholar
• Tadmor T, Polliack A. Epidemiology and environmental risk in hairy cell leukemia. Best Pract Res Clin Haematol. 2015;28(4):175–179.
   PubMed Web of Science ®Google Scholar
• Metayer C, Dahl G, Wiemels J, et al. Childhood leukemia: a preventable disease. Pediatrics. 2016;138(Suppl. 1):S45–S55.
   PubMed Web of Science ®Google Scholar
• Williams LA, Yang JJ, Hirsch BA, et al. Is there etiologic heterogeneity between subtypes of childhood acute lymphoblastic leukemia? A review of variation in risk by subtype. Cancer Epidemiol Biomarkers Prev. 2019;28(5):846–856.
   PubMed Web of Science ®Google Scholar
• Barrington-Trimis JL, Cockburn M, Metayer C, et al. Trends in childhood leukemia incidence over two decades from 1992 to 2013. Int J Cancer. 2017;140(5):1000–1008.
   PubMed Web of Science ®Google Scholar
• Bazyka D, Finch S, Ilienko I, et al. Buccal mucosa micronuclei counts in relation to exposure to low dose-rate radiation from the Chornobyl nuclear accident and other medical and occupational radiation exposures. Environ Health. 2017;16(1):23–70.
   PubMed Web of Science ®Google Scholar
• Sun CC, Li SJ, Chen ZL, et al. Expression and prognosis analyses of runt-related transcription factor family in human leukemia. Mol Ther Oncolyt. 2019;12:103–111.
   PubMed Web of Science ®Google Scholar
• Rabbitts TH. Translocations, master genes, and differences between the origins of acute and chronic leukemias. Cell. 1991;67(4):641–644.
   PubMed Web of Science ®Google Scholar
• Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3(7):730–737.
   PubMed Web of Science ®Google Scholar
• Shallis RM, Wang R, Davidoff A, et al. Epidemiology of acute myeloid leukemia: recent progress and enduring challenges. Blood Rev. 2019;36:70–87.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.
   PubMed Web of Science ®Google Scholar
• Tan TK, Zhang C, Sanda T. Oncogenic transcriptional program driven by TAL1 in T-cell acute lymphoblastic leukemia. Int J Hematol. 2019;109(1):5–17.
   PubMed Web of Science ®Google Scholar
• Mrózek K, Marcucci G, Paschka P, et al. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?. Blood. 2007;109(2):431–448.
   PubMed Web of Science ®Google Scholar
• Consoli ML, Romano A, Parrinello NL, et al. Unusual karyotype in acute myelomonocitic leukemia: a case report. Anticancer Res. 2019;39(8):4329–4332.
   PubMed Web of Science ®Google Scholar
• Li S, Bian H, Cao Y, et al. Identification of novel lncRNAs involved in the pathogenesis of childhood acute lymphoblastic leukemia. Oncol Lett. 2019;17(2):2081–2090.
   PubMed Web of Science ®Google Scholar
• Schlenk RF, Döhner K, Krauter J, et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med. 2008;358(18):1909–1918.
   PubMed Web of Science ®Google Scholar
• Canaani J, Labopin M, Itälä-Remes M, et al. Prognostic significance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemia. Leukemia. 2019;33(8):1944–1952.
   PubMed Web of Science ®Google Scholar
• Wang SY, Cheng WY, Mao YF, et al. Genetic alteration patterns and clinical outcomes of elderly and secondary acute myeloid leukemia. Hematol Oncol. 2019;37(4):456–463.
   PubMed Web of Science ®Google Scholar
• Patel JP, Gönen M, Figueroa ME, et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med. 2012;366(12):1079–1089.
   PubMed Web of Science ®Google Scholar
• Papaemmanuil E, Gerstung M, Bullinger L, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374(23):2209–2221.
   PubMed Web of Science ®Google Scholar
• Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005;4(1):7.
   Web of Science ®Google Scholar
• Ruan J, Dean AK, Zhang W. A general co-expression network-based approach to gene expression analysis: comparison and applications. BMC Syst Biol. 2010;4(1):8.
   PubMed Web of Science ®Google Scholar
• Yang Y, Han L, Yuan Y, et al. Gene co-expression network analysis reveals common system-level properties of prognostic genes across cancer types. Nat Commun. 2014;5:3231.
   PubMed Web of Science ®Google Scholar
• Most D, Leiter C, Blednov YA, et al. Synaptic microRNAs coordinately regulate synaptic mRNAs: perturbation by chronic alcohol consumption. Neuropsychopharmacology. 2016;41(2):538–548.
   PubMed Web of Science ®Google Scholar
• Casero D, Sandoval S, Seet CS, et al. Long non-coding RNA profiling of human lymphoid progenitor cells reveals transcriptional divergence of B cell and T cell lineages. Nat Immunol. 2015;16(12):1282–1291.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Jaramillo V, Portilla-Fernandez E, Glisic M, et al. The role of DNA methylation and histone modifications in blood pressure: a systematic review. J Hum Hypertens. 2019;33(10):703–715.
   PubMed Web of Science ®Google Scholar
• Pan JQ, Zhang YQ, Wang JH, et al. lncRNA co-expression network model for the prognostic analysis of acute myeloid leukemia. Int J Mol Med. 2017;39(3):663–671.
   PubMed Web of Science ®Google Scholar
• Luo M, Zhang Q, Xia M, et al. Differential co-expression and regulatory network analysis uncover the relapse factor and mechanism of t cell acute leukemia. Mol Ther Nucleic Acids. 2018;12:184–194.
   PubMedGoogle Scholar
• Saadatpour A, Guo G, Orkin SH, et al. Characterizing heterogeneity in leukemic cells using single-cell gene expression analysis. Genome Biol. 2014;15(12):525.
   PubMed Web of Science ®Google Scholar
• O'Neill K, Zhang F, Li H, et al. Thymidine kinase 1-a prognostic and diagnostic indicator in ALL and AML patients. Leukemia. 2007;21(3):560–563.
   PubMed Web of Science ®Google Scholar
• Ong YL, McMullin MF, Bailie KEM, et al. High bax expression is a good prognostic indicator in acute myeloid leukaemia. Br J Haematol. 2000;111(1):182–189.
   PubMed Web of Science ®Google Scholar
• Falini B, Nicoletti I, Martelli MF, et al. Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc + AML): biologic and clinical features. Blood. 2007;109(3):874–885.
   PubMed Web of Science ®Google Scholar
• Teng F, Meng X, Wang X, et al. Expressions of CD8 + TILs, PD-L1 and Foxp3 + TILs in stage I NSCLC guiding adjuvant chemotherapy decisions. Oncotarget. 2016;7(39):64318–64329.
   PubMedGoogle Scholar
• Mandai M, Hamanishi J, Abiko K, et al. Immunology and immunotherapy in ovarian cancer. In: Frontiers in ovarian cancer science. Heidelberg, Germany: Springer; 2017. p. 225–242.
   Google Scholar
• Zhao Q, Cao L, Guan L, et al. Immunotherapy for gastric cancer: dilemmas and prospect. Brief Funct Genomics. 2019;18(2):107–112.
   PubMed Web of Science ®Google Scholar
• Bedognetti D, Hendrickx W, Marincola FM, et al. Prognostic and predictive immune gene signatures in breast cancer. Curr Opin Oncol. 2015;27(6):433–444.
   PubMed Web of Science ®Google Scholar
• Ma X, Park Y, Mayne ST, et al. Diet, lifestyle, and acute myeloid leukemia in the NIH–AARP cohort. Am J Epidemiol. 2010;171(3):312–322.
   PubMed Web of Science ®Google Scholar
• Chyla BJ, Harb J, Mantis C, et al. Response to venetoclax in combination with low intensity therapy (LDAC or HMA) in untreated patients with acute myeloid leukemia patients with IDH, FLT3 and other mutations and correlations with BCL2 family expression. Blood. 2019;134(Supplement_1):546–546.
   Web of Science ®Google Scholar
• Pollyea DA, Stevens BM, Jones CL, et al. Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia. Nat Med. 2018;24(12):1859–1866.
   PubMed Web of Science ®Google Scholar
• Bryan TO, Neil O, Gary RF, et al. Follow the ATP: tumor energy production: a perspective. Anticancer Agents Med Chem. 2014;14(9):1187–1198.
   PubMed Web of Science ®Google Scholar
• Chen WL, Wang YY, Zhao A, et al. Enhanced fructose utilization mediated by SLC2A5 is a unique metabolic feature of acute myeloid leukemia with therapeutic potential. Cancer Cell. 2016;30(5):779–791.
   PubMed Web of Science ®Google Scholar
• Ignatz-Hoover JJ, Wang H, Moreton SA, et al. The role of TLR8 signaling in acute myeloid leukemia differentiation. Leukemia. 2015;29(4):918–926.
   PubMed Web of Science ®Google Scholar
• Payton JE, Grieselhuber NR, Chang LW, et al. High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples. J Clin Invest. 2009;119(6):1714–1726.
   PubMed Web of Science ®Google Scholar
• Nagata H, Kozaki K-I, Muramatsu T, et al. Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma. Oncotarget. 2017;8(23):37740–37750.
   PubMedGoogle Scholar
• Pertesi M, Ekdahl L, Palm A, et al. Essential genes shape cancer genomes through linear limitation of homozygous deletions. Commun Biol. 2019;2:262.
   PubMed Web of Science ®Google Scholar
• Abe M, Hamada J-I, Takahashi O, et al. Disordered expression of HOX genes in human non-small cell lung cancer. Oncol Rep. 2006;15(4):797–802.
   PubMed Web of Science ®Google Scholar
• Hur H, Lee JY, Yun HJ, et al. Analysis of HOX gene expression patterns in human breast cancer. Mol Biotechnol. 2014;56(1):64–71.
   PubMed Web of Science ®Google Scholar
• Kuo TL, Cheng KH, Chen LT, et al. Deciphering the potential role of Hox genes in pancreatic cancer. Cancers. 2019;11(5):734.
   Web of Science ®Google Scholar
• Abo Elwafa R, Gamaleldin M, Ghallab O. The clinical and prognostic significance of FIS1, SPI1, PDCD7 and Ang2 expression levels in acute myeloid leukemia. Cancer Genet. 2019;233–234:84–95.
   PubMed Web of Science ®Google Scholar